Versican immunoreactivity was found to be less intense in areas adjacent to in situ carcinomatous regions compared to invasive regions, which exhibited extensive and strong staining, suggesting a direct relationship between versican and tumor invasiveness. Here, VCAN is linked to neoplasm.